eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
vol. 4

Clinical research
A systematic review of Iranian medicinal plants useful in diabetes mellitus

Shirin Hasani-Ranjbar
Bagher Larijani
Mohammad Abdollahi

Arch Med Sci 2008; 4, 3: 285–292
Online publish date: 2008/10/15
Article file
- A systematic.pdf  [0.09 MB]
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero

The term diabetes mellitus describes several diseases of abnormal carbohydrate metabolism that are characterized by hyperglycaemia. It is associated with a relative or absolute impairment in insulin secretion, along with varying degrees of peripheral resistance to the action of insulin. Today about 2 565 500 people, equal to 6% of the population in the age group of 20-79 years, are suffering from diabetes mellitus in Iran; its prevalence is increasing as in other developing countries and is expected to reach 5 114 900 in 2025 [1]. For a very long time, plants have played an important role in the treatment of many diseases, especially in Eastern countries. The use of plants for treatment of diabetes has been common in the Iranian population too. These natural compounds are used by traditional herbalists for the management of diabetes in several parts of Iran [2]. There are enough reports on the positive effects of herbal medicines in the management of diabetes [3-45]. However, available herbal products have no clear statement of content or medically related information on the package labels, and they have not been validated or certified. For various reasons, in recent years the popularity of alternative medicine has increased. Surveys conducted in Australia and the U.S. indicate that almost 48.5 and 34% of respondents respectively had used at least one form of unconventional therapy, including herbal medicine. The WHO has also recommended evaluation of effective plants for conditions such as diabetes for which there are few safe modern drugs [46]. This leads to increasing demand for herbal products with anti-diabetic activity and fewer side effects. At the time being, some herbal preparations are used by diabetic patients in Iran, especially among unsuccessfully treated patients and those who are candidates for insulin therapy [2]. Most studies published in Iran have shown a statistically significant decrease in blood glucose but no there are no collective data and no systematic review has been performed yet. This is the first review that focuses on the efficacy and safety of Iranian medicinal plants in the management of diabetes.
Material and methods
The data sources EMBASE, Scopus, PubMed, Web of Science, Google Scholar, and IranMedex databases were searched up to 8th October 2007 for studies investigating medicinal plants in prevention and treatment of diabetes. The search terms were “diabetes” and “plant”, “herb”, “traditional”, and “natural” or “herbal medicine”, limited to Iran. The reference lists of articles were also reviewed for additional relevant studies.
Study selection

Inclusion criteria
All of the human studies with the key outcome of change in blood glucose or serum lipids in diabetic patients were included. Animal studies with the outcome of change in blood glucose, serum lipids, antioxidant parameters, hepatic enzymes, anti-inflammation, and vascular activity were also included.
Exclusion criteria
In vitro studies, review articles and letters to the editor were excluded. Unpublished data such as theses were not included. Studies published from countries other than Iran were excluded too. Two reviewers independently examined the title and abstract and references of each article to eliminate duplications, those published from countries other than Iran, and in vitro studies. The reviewers independently extracted data on the medicinal plant, dose, trial duration, sample size, outcome, results, and side effects.

Human studies
Of publications identified in the initial database search, 12 trials on the efficacy of medicinal plants in diabetic patients were reviewed. Information from these clinical trials are summarized in Table I.
Blood glucose
The key outcome for anti-diabetic effects was reduction in blood glucose. These human studies showed a significant decrease in blood glucose after treatment with Citrullus colocynthus L., Silybum marianum, Psyllium, Teucrium polium, and Pomegranate [4, 6-12]. Securigera securidaca (1500 mg/day) had no benefit on improving glycaemic profile in type 2 diabetic patients [3]. Salvia leriifolia and Morus nigra had no hypoglycaemic effect but neuropathy and polyphagia became better during administration of the extracts [13, 14].
Serum lipids
Another key outcome in diabetes was reduction in serum lipids. In a before-after clinical trial, Garlic tablets significantly decreased total and LDL cholesterol levels in diabetic patients with hyperlipidaemia [5]. Improvement in lipid profile was shown by other medicinal plants including Silybum marianum, Psyllium, Teucrium polium, and Pomegranate [6-10, 12].
Side effects
The use of Securigera securidaca in the dose of 1500 mg in divided doses showed no gastrointestinal symptoms or liver and kidney abnormalities during two months of therapy [3]. Ten percent of patients treated with Citrullus colocynthis L. in the dose of 300 mg in three divided doses complained of mild diarrhoea [4]. No side effects were recorded with Psyllium (10 g/day) and an even better response to metformin was found [7, 9]. No adverse effects were reported for chronic use of Silybum marianum [6].
Animal studies
The details of the animal studies that investigated Iranian medicinal plants in animal diabetic models are summarized in Table II.
Blood glucose
The key outcome for anti-diabetic drugs in animal studies was reduction in blood glucose. These animal studies showed that Walnut leaf, coriander, Pomegranate, Garlic, Satureja khuzestanica, Phlomis anisodonta, Trigonella foenum graecum, olive (Olea europaea L.), Capsicum frutescens, Achillea santolina, Aloe vera, Salvia officinalis, Anathum graveolens, Teucrium polium, Urtica dioica, Morus nigra, Morus alba, Salvia lenifolia benth leaf, and Cynara scolymus improve blood glucose of diabetic animals.
Serum lipids
Improvement in lipid profile was shown by some medicinal plants including Satureja khuzestanica, Capsicum frutescens, Garlic, Aloe vera, Anathum graveolens, Persian Walnut, tarragon, and Cynara scolymus. In one study, Teucrium polium in a dose of 50 mg/kg increased blood lipid levels [39].
In Iran, there are multiple plants that are unofficially taken by diabetic patients [2]. The present data show that some of these plants (Citrullus colocynthus L., Silybum marianum, Psyllium, Teucrium polium, and Pomegranate) are really effective in reducing blood glucose in diabetic patients [4, 6-12]. Animal studies have also shown that some natural plants are even more effective than currently used chemical drugs in diabetic animals [24, 27]. Special attention to these natural compounds seems necessary to search for novel therapeutic agents. Some of these plants have shown a significant hypoglycaemic effect in animals but not in humans (e.g. Garlic, Salvia leriifolia, Morus nigra, and Securigera securidaca) [3, 5, 13, 14, 17, 27, 35, 37, 41]. This controversy seems to be due to inappropriately designed clinical trials; it thus remains to be elucidated by further examinations in diabetic patients. It is notable that the hypoglycaemic effect of these herbal medicines can interfere with hypoglycaemic drugs and insulin, which are standard treatments for diabetic patients. Most physicians advise their patients to avoid herbal medicine, but in some cases the diabetic patients take it without informing their physicians [2]. This type of herbal therapy may lead to drug interaction or false and unstable blood glucose level monitoring [2]. Therefore, physicians should have adequate knowledge about herbal medicines effective in blood glucose to be prepared how to manage patients who are at risk. Any consumption of medicinal plants must be under the supervision of physicians. Some of these plants (Garlic, Silybum marianum, Psyllium, Teucrium polium, and Pomegranate) had anti-hyperlipidaemic properties and this reduction in serum lipids was statistically significant. Of course there were two controversial reports about Teucrium polium affecting blood lipid profile [12, 39], which needs to be proved by further studies. The medicinal plants with lipid-lowering potential can better be supplemented to standard therapy of diabetic patients. Investigation of other clinical trials in different parts of the world can help us to recommend a proper dose for diabetic patients. For some of these plants (Garlic and Pomegranate), proper randomized controlled trials are needed show their benefit in diabetic patients. Induction of insulin release is the mechanism of action for some medicinal plants, including Phlomis anisodonta, olive (Olea europaea L.), Garlic, Teucrium polium, and Urtica dioica [19, 24, 27, 34, 36]. In addition, density of islets in pancreatic tissue, percent of beta cells and islets size increased significantly in rats treated with Walnut leaf and Garlic [15, 17]. It has been suggested that enhanced production of free radicals and oxidative stress are central events to the development of diabetic complications. Use of antioxidants reduces oxidative stress and alleviates diabetic complications [47]. Most of the tested medicinal plants (e.g. Achillea santolina, Phlomis anisodonta, ginger) have shown antioxidant effects [19, 26, 29]. Further studies in diabetic animal models and also diabetic patients should be better focused on those Iranian herbal medicines that have been found to have adequate antioxidant effects in humans and some tested in disease models other than diabetes [48-60]. In conclusion, any consumption of medicinal plants must be under the supervision of physicians. Some natural plants are more effective than currently used chemical drugs in diabetic patients [24, 27]. Special attention to these natural compounds would open a new approach for novel therapeutic agents.
1. Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. In: Delice Gan Diabetes Atlas. 3rd ed. International Diabetes Federation 2007; 51. 2. Fallah-Hoseini H, Fakhrzadeh H, Larijani B, Shikhsamani A. Review of anti-diabetic medicinal plant used in traditional medicine. J Med Plant 2006; 5 (Suppl 2): 1-8. 3. Fallah-Hoseini H, Hooseini P, Heshmat R, et al. The clinical investigation of Securigera securidaca (L.) (Degen & Doerfler) seeds in treatment of type II diabetic patients; a randomized, double-blind, placebo-controlled study. J Med Plant 2006; 5: 75-9. 4. Fallah-Hoseini H, Heshmat R, Larijani B, et al. The clinical investigation of Citrullus Colocynthis (L.) Schrad. Fruit in treatment of type II diabetic patients: A randomized, double-blind, placebo-controlled study. J Med Plant 1384; (5): 31-5. 5. Parastouei K, Ravanshad S, Mostaphavi H, Setoudehmaram E. Effects of garlic tablet on blood sugar, plasma lipids and blood pressure in type 2 diabetic patients with hyperlipidemia. J Med Plant 2006; 5 (Suppl) 2: 48-54. 6. Fallah-Hoseini H, Larijani B, Heshmat R, et al. The efficacy of Silybum marianum (L) Gaertn (silymarin) in the treatment of type II diabetes: A randomized, double-blind, placebo-controlled, clinical trial. Phytother Res 2006; 20: 1036-9. 7. Ziai SA, Larijani B, Akhoondzadeh S, et al. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol 2005; 102: 202-7. 8. Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L. Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. J Med Food 2004; 7: 305-8. 9. Ziai SA, Larijani B, Fakhrzadeh H, et al. Study of Psyllium (Plantago ovata L.) effects on diabetes and lipidemia in the Iranian type II diabetic patients. J Med Plant 2004; 3: 41-50. 10. Fallah-Hoseini H, Larijani B, Fakhrzadeh H, et al. The clinical trial of Silybum Marianum seed extract (Silymarin) on type II diabetic patients with hyperlipidemia. Irn J Diabetes Lipid Disord 1383; 2: 201-6. 11. Fallah-Hoseini H, Zarei BA, Heshmat R, et al. The effect of Citrullus Colocynthis (L.) Schrad fruit on oxidative stress parameters in type II diabetic patients. J Med Plant 1384; 5: 55-60. 12. Karimi F, Abbasi S, Bateni A. The effect of Teucrium polium on blood glucose in diabetes mellitus type 2; A comparison with glibenclamide. Iran South Med J 1380; 2: 103-9. 13. Hosseinzadeh H, Khazaei MH, Montazami S. Clinical trial of antidiabetic effect of Salvia Leriifolia leaves extracts. Irn J Basic Med Sci 1380; 2: 71-83. 14. Khazaei MH, Hosseinzadeh H, Kazemi L. Clinical trial of antidiabetic effect of Morus Nigra leave extracts. Irn J Basic Med Sci 1381; 1: 27-34. 15. Jelodar G, Mohsen M, Shahram S. Effect of walnut leaf, coriander and pomegranate on blood glucose and histopathology of pancreas of alloxan induced diabetic rats. Africa J Tradit Complement Altern Med 2007; 4: 299-305. 16. Eidi A, Eidi M, Sokhteh M. Effect of alcoholic extracts fenugreek seeds (Trigonella foenum graceum L.) in the activity of hepatic enzymes in normal and diabetic rats. J Med Plant 2006; 5 (Suppl) 2: 36-41. 17. Jelodar GA, Maleki M, Motadayen MH, Sirus S. Effect of fenugreek, onion and garlic on blood glucose and histopathology of pancreas of alloxan-induced diabetic rats. Indian J Med Sci 2005; 59: 64-9. 18. Abdollahi M, Salehnia A, Mortazavi SH, et al. Antioxidant, antidiabetic, antihyperlipidemic, reproduction stimulatory properties and safety of essential oil of Satureja Khuzestanica in rat in vivo: A toxicopharmacological study. Med Sci Monit 2003; 9: BR331-5. 19. Sarkhail P, Rahmanipour S, Fadyevatan S, et al. Antidiabetic effect of Phlomis anisodonta: Effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Pharmacol Res 2007; 56: 261-6. 20. Roghani M, Baluchnejadmojarad T. The role of L-type calcium channels in the vascular effect of Trigonella foenum-graecum L. in diabetic rats. Daru 2006; 14: 1-5. 21. Roghani M, Baluchnejadmojarad T. Time-dependent changes in responsiveness of thoracic aorta of diabetic rats to quercetin. J Med Plant 2006; 5 (Suppl) 2: 42-7. 22. Morshedi A, Dashti MH, Mosaddegh MH, Rafati A, Salami AS. The chronic effect of Kombucha Tea consumption on weight loss in diabetic rats. J Med Plant 2006; 5 (Suppl) 2: 17-22. 23. Zahediasl S, Saharnaz F, Ghassemi A, Zaree B. Effect of the carbon tetrachloride extract of Trigonella foenum graecum seeds on the glycogen content of liver in diabetic rats. J Med Plant 2006; 5 (Suppl) 2: 9-16. 24. Eidi A, Eidi M, Oryan SH, Fallahyan F, Darounkala RD. Hypoglycaemic effect of alcoholic extract of olive (Olea europaea L.) leaf in healthy and diabetic rats. J Med Plant 2004; 3: 36-40. 25. Roghani M, Baluchnejadmojarad T, Sohrabi Z, Sadeghi M. Anti-hyperglycemic and hypolipidemic effect of oral administration of Capsicum Frutescens in male STZ-diabetic rats. J Med Plant 1983; 10: 47-52. 26. Yazdanparast R, Ardestani A, Jamshidi S. Experimental diabetes treated with Achillea santolina: Effect on pancreatic oxidative parameters. J Ethnopharmacol 2007; 112: 13-8. 27. Eidi A, Eidi M, Esmaeili E. Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic rats. Phytomedicine 2006; 13: 624-9. 28. Jadidoleslami M, Nejad MA, Shahraki MR. The effect of aloe vera aqueous extract on glucose and lipid levels in diabetic male rats. Irn J Diabetes Lipid Disord 2006; 6: E18. 29. Afshari AT, Shirpoor A, Farshid A, et al. The effect of ginger on diabetic nephropathy, plasma antioxidant capacity and lipid peroxidation in rats. Food Chem 2006; 101: 148-53. 30. Reza JZ, Dousti M, Soleimani S, et al. Effects of Persian walnut (Lavasanatregion) oil extract on lipid profile in animal model (Hypercholesterolemic male Rats). Irn J Diabetes Lipid Disord 2006; 5: 39-44. 31. Fatehi-Hassanabad Z, Gholamnezhad Z, Jafarzadeh M, Fatehi M. The anti-inflammatory effects of aqueous extract of ginger root in diabetic mice. Daru 2005; 13: 70-3. 32. Eidi M, Eidi A, Zamanizadeh H. Effect of Salvia officinalis L. leaves on serum glucose and insulin in healthy and streptozotocin-induced diabetic rats. J Ethnopharmacol 2005; 100: 310-3. 33. Madani H, Mahmoodabady NA, Vahdati A. Effects of hydroalcoholic extract of Anethum graveolens (Dill) on plasma glucose and lipid levels in diabetes induced rats. Irn J Diabetes Lipid Disord 2005; 5: E13+E13i-E13viii. 34. Yazdanparast R, Esmaeili MA, Helan JA. Teucrium polium extract effects pancreatic function of streptozotocin diabetic rats: A histopathological examination. Irn Biomed J 2005; 9: 81-5. 35. Baluchnejadmojarad T, Roghani M. Endothelium-dependent and -independent effect of aqueous extract of garlic on vascular reactivity on diabetic rats. Fitoterapia 2003; 74: 630-7. 36. Farzami B, Ahmadvand D, Vardasbi S, Majin FJ, Khaghani S. Induction of insulin secretion by a component of Urtica dioica leave extract in perifused Islets of Langerhans and its in vivo effects in normal and streptozotocin diabetic rats. J Ethnopharmacol 2003; 89: 47-53. 37. Hosseinzadeh H, Ramezani M, Danaei AR. Antihyperglycaemic effect and acute toxicity of Securigera Securidaca L. seed extracts in mice. Phytother Res 2002; 16: 745-7. 38. Hosseinzadeh H, Sadeghi A. Antihyperglycemic effects of Morus nigra and Morus Alba in mice. Pharm Pharmacol Lett 1999; 9: 63-5. 39. Shahraki MR, Arab MR, Mirimokaddam E, Palan MJ. The effect of Teucrium polium (Calpoureh) on liver function, serum lipids and glucose in diabetic male rats. Irn Biomed J 2007; 11: 65-8. 40. Saeb M, Gelodar G, Ghaedipour N, Sajedianfard J. The effect of thirteen plants on arginase, creatine kinase, amylase and lipase activities of the serum in diabetic rats. J Kerman Univ Med Sci 1374; 4: 193-9. 41. Hosseinzadeh H, Khodaparast MH, Shokoohizadeh H. Antihyperglycemic activity of Salvia Leriifolia benth leaf and seed extracts in mice. Irn J Med Sci 1998; 4-3: 94-8. 42. Chandra A, Mahdi AA, Rizvi W, Singh RK, Ahmad S, Mishra LC. Effect of herbal hypoglycemic agents on antioxidant enzymes and metal ions in streptozotocin-induced diabetic rats. Irn J Diabetes Lipid Disord 1383; 1: 19-26. 43. Arzi A, Zahedi S, Ghanavati J. Study of the effect of Morus Alba leaves exctracts on streptozotocin induced diabetes in mice. Sci Med J Ahwaz Univ Med Sci 1380; 30: 27-34. 44. Roghani M, Baluchnejadmojarad T, Roghani-Dehkordi F. The effect of oral administration of artemisia dracunculus on blood glucose and lipid profile in male diabetic rats. Irn J Endocrinol Metab 1383; 23: 235-9. 45. Mahmoodabadi NA, Madani H, Mahzooni P, Vahdati A. Preventive effect of hydroalcoholic Cynara scolymus extract on appearance of type 1 diabetes mellitus in male rats. Irn J Diabetes Lipid Disord 2006; 6: E5. 46. Kim JD, Kang SM, Park MY, Jung TY, Choi HY, Ku SK. Ameliorative anti-diabetic activity of dangnyosoko, a Chinese herbal medicine, in diabetic rats. Biosci Biotechnol Biochem 2007; 71: 1527-34. 47. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005; 59: 365-73. 48. Dehghan G, Shafiee A, Ghahremani MH, Ardestani SK, Abdollahi M. Antioxidant potential of various extracts from ferula szovitsiana in relation to their phenolic content. Pharm Biol 2007; 45: 691-9. 49. Dehghan G, Solaimanian R, Shahverdi AR, Amin G, Abdollahi M, Shafiee A. Chemical composition and antimicrobial activity of essential oil of Ferula szovitsiana D.C. Flav Fragr J 2007; 22: 224-7. 50. Mehdipour S, Yasa N, Dehghan G, et al. Antioxidant potentials of Iranian Carica papaya juice in vitro and in vivo are comparable to alpha-tocopherol. Phytother Res 2006; 20: 591-4. 51. Ranjbar A, Khorami S, Safarabadi M, et al. Antioxidant activity of Iranian Echium amoenum Fisch & C.A. Mey flower decoction in humans: a cross-sectional before/after clinical trial. Evid Based Complement Alternat Med 2006; 3: 469-73. 52. Shahriari S, Yasa N, Mohammadirad A, Khorasani R, Abdollahi M. In vivo antioxidant potentials of Rosa Damascene Petal extract from Guilan, Iran, Comparable to alpha-tocopherol. Int J Pharmacol 2006; 2: 646-9. 53. Ranjbar A, Ghaseminejhad S, Takalu H, Baiaty A, Rahimi F, Abdollahi M. Anti oxidative stress potential of cinnamon (Cinnamomum zeylanicum) in operating room personnel; a before/after cross sectional clinical trial. Int J Pharmacol 2007; 3: 482-6. 54. Ranjbar A, Ghasmeinezhad S, Zamani H, et al. Antioxidative stress potential of Cinnamomum zeylanicum in humans: a comparative cross-sectional clinical study. Therapy 2006; 3: 113-7. 55. Ashtaral-Nakhai L, Mohammadirad A, Yasa N, et al. Benefits of Zataria multiflora Boiss in experimental model of mouse inflammatory bowel disease. Evid Based Complement Alternat Med 2007; 4: 43-50. 56. Ghafari H, Yasa N, Mohammadirad A, et al. Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity. Hum Exp Toxicol 2006; 25: 325-32. 57. Ghazanfari G, Minaie B, Yasa N, et al. Biochemical and histopathological evidences for beneficial effects of Satureja khuzestanica jamzad essential oil on the mouse model of inflammatory bowel diseases. Toxicol Mech Methods 2006; 16: 365-72. 58. Haeri S, Minaie B, Amin G, et al. Effect of Satureja khuzestanica essential oil on male rat fertility. Fitoterapia 2006; 77: 495-9. 59. Saadat M, Pournourmohammadi S, Donyavi M, et al. Alteration of rat hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities by Satureja khuzestanica Jamzad essential oil. J Pharm Pharm Sci 2004; 7: 327-31. 60. Basiri S, Esmaily H, Vosough-Ghanbari S, Mohammadirad A, Yasa N, Abdollahi M. Improvement by Satureja khuzestanica essential oil of malathion-induced red blood cells acetylcholinesterase inhibition and altered hepatic mitochondrial glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities. Pest Biochem Physiol 2007; 89: 124-9.
Copyright: © 2008 Termedia & Banach. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe